Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Canfell

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Sexual Health|August 20, 2010
Models of cervical screening in the era of human papillomavirus vaccinationKaren Canfell
BMJ (Clinical Research Ed.)|September 9, 2015
HPV vaccination and pregnancyKaren Canfell
Nature Medicine|May 20, 2026
HPV vaccines, 20 years onKaren Canfell
BMJ (Clinical Research Ed.)|May 19, 2015
Who should be vaccinated against HPV?Karen Canfell
BMJ (Clinical Research Ed.)|March 26, 2010
Monitoring HPV vaccination programmesKaren Canfell
Papillomavirus Research (Amsterdam, Netherlands)|June 10, 2019
Towards the global elimination of cervical cancerKaren Canfell
Vaccine|August 31, 2014
Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countriesLeonardo Simonella, Karen Canfell
Breast Cancer Research : BCR|March 19, 2010
Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsibleEmily Banks, Karen Canfell
American Journal of Epidemiology|May 27, 2009
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesisEmily Banks, Karen Canfell
Cancer Causes & Control : CCC|July 9, 2013
The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and EnglandLeonardo Simonella, Karen Canfell
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Sexual Health|August 20, 2010
Models of cervical screening in the era of human papillomavirus vaccinationKaren Canfell
BMJ (Clinical Research Ed.)|September 9, 2015
HPV vaccination and pregnancyKaren Canfell
Nature Medicine|May 20, 2026
HPV vaccines, 20 years onKaren Canfell
BMJ (Clinical Research Ed.)|May 19, 2015
Who should be vaccinated against HPV?Karen Canfell
BMJ (Clinical Research Ed.)|March 26, 2010
Monitoring HPV vaccination programmesKaren Canfell
Papillomavirus Research (Amsterdam, Netherlands)|June 10, 2019
Towards the global elimination of cervical cancerKaren Canfell
Vaccine|August 31, 2014
Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countriesLeonardo Simonella, Karen Canfell
Breast Cancer Research : BCR|March 19, 2010
Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsibleEmily Banks, Karen Canfell
American Journal of Epidemiology|May 27, 2009
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesisEmily Banks, Karen Canfell
Cancer Causes & Control : CCC|July 9, 2013
The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and EnglandLeonardo Simonella, Karen Canfell
Pageof 35